Home Healthcare Biotechnology Immunoglobulins Market

Immunoglobulins Market Size, Share & Trends Analysis Report By Product (IgG, IgA, IgM, IgE, IgD), By Mode of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 29, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
  7. North America Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
  8. Europe Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
  9. APAC Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
  10. Middle East and Africa Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
  11. LATAM Immunoglobulins Market Size Analysis
    1. Introduction
    2. Immunoglobulins Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. IgG
      2. IgA
      3. IgM
      4. IgE
      5. IgD
    3. Immunoglobulins Market Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
      1. Intravenous Mode of Delivery
      2. Subcutaneous Mode of Delivery
    4. Immunoglobulins Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
      3. Immunodeficiency Disease
      4. Myasthenia Gravis
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. IgG
        2. IgA
        3. IgM
        4. IgE
        5. IgD
      3. Market Size & Forecast By Mode of Delivery 2022-2034 (USD MILLION/ Units)
        1. Intravenous Mode of Delivery
        2. Subcutaneous Mode of Delivery
      4. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
        3. Immunodeficiency Disease
        4. Myasthenia Gravis
  12. Competitive Landscape
    1. Immunoglobulins Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Baxter International Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. CSL Ltd
    3. Grifols SA
    4. Octapharma AG
    5. Kedrion Biopharma Inc.
    6. LFB group
    7. Biotest AG
    8. China Biologics Products Inc.
    9. Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
    10. Bayer Healthcare
    11. Takeda Pharmaceutical Company Limited
    12. Bio Products Laboratory
    13. Sanquin Plasma Products B.V.
    14. Evolve Biologics Inc.
    15. Pfizer Inc.
    16. Shanghai RAAS Blood Products Co. Ltd
    17. ADMA Biologics Inc.
    18. KORU Medical Systems
    19. Kamada Ltd.
    20. GC Biopharma
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.